Latest MS research news

Latest MS research news | 06 August 2013

Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk

This study looked at the association between MS risk and anti-Epstein-Barr virus (EBV)-specific antibody levels in addition to HLA-DR profiles, gender and age in a population-based cohort involving 426 people with MS ...

From MSIF

Latest MS research news | 06 August 2013

Association between multiple sclerosis risk-associated SNPs and relapse and disability - a prospective cohort study

This study from Australia investigated if known MS risk-associated single-nucleotide polymorphisms (SNPs) were associated with clinical course and if these SNPs modified the 25(OH)D-relapse association.

From MSIF

Latest MS research news | 30 July 2013

Contribution of cortical lesion subtypes at 7T MRI to physical and cognitive performance in MS

This study looked at the different types of cortical lesions at ultra-high field MRI and their contribution to neurological disability and cognitive performance in 34 people with RRMS, SPMS and clinically isolated syndrome.

From MSIF

Latest MS research news | 30 July 2013

Novel modulating effects of PKC family genes on the relationship between serum vitamin D and relapse in multiple sclerosis

This study from Australia looks at the interaction between genes and environmental factors on the clinical course of MS.

From MSIF

Latest MS research news | 30 July 2013

Iron and neurodegeneration in the multiple sclerosis brain

This study looked at the distribution of non-heme iron as well as the expression of the iron-related proteins ferritin, hephaestin and ceruloplasmin as regards the oxidative damage in the brain tissue of 33 people with MS and 30 controls.

From MSIF

Latest MS research news | 23 July 2013

Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial

This multicentre, double-blinded, placebo-controlled study looked at dronabinol, a cannabinoid which may have neuroprotective effects on progressive MS.

From MSIF

Latest MS research news | 23 July 2013

Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter

This study assessed the correlation between cortical lesion load on 7T MRI and the magnetisation transfer ratio (MTR) of the normal appearing white matter (NAWM), in order to test the hypothesis that cortical ...

From MSIF

Latest MS research news | 23 July 2013

Multiple sclerosis: identification of temporal changes in brain lesions with computer-assisted detection software

This study from the US looked at the performance of a locally developed computer-assisted detection (CAD) software, which they used to track temporal changes in MS brain lesions.

From MSIF

Latest MS research news | 16 July 2013

Vitamin D levels and risk of MS in patients with CIS

In this retrospective study from Italy the researchers looked at serum 25-hydroxyvitamin D (25(OH)D) levels in people with clinically isolated syndrome (CIS) and the associated risk of MS.

From MSIF

Latest MS research news | 15 July 2013

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

This study group evaluated if IFNB-1b in patients with clinically isolated syndrome (CIS) prevented persisting T1 hypointensities on MRI (persistent black holes (PBHs)).

From MSIF
 

Latest MS research news

Main MS research areas

Challenges of MS research